Does OBINUTUZUMAB Cause Flushing? 124 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Flushing have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.9% of all adverse event reports for OBINUTUZUMAB.
124
Reports of Flushing with OBINUTUZUMAB
0.9%
of all OBINUTUZUMAB reports
2
Deaths
28
Hospitalizations
How Dangerous Is Flushing From OBINUTUZUMAB?
Of the 124 reports, 2 (1.6%) resulted in death, 28 (22.6%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Flushing Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Flushing?
DIMETHYL (10,681)
TREPROSTINIL (3,166)
TECFIDERA (2,385)
AMBRISENTAN (1,741)
DALFAMPRIDINE (1,605)
DIROXIMEL (1,518)
INFLIXIMAB (1,488)
PACLITAXEL (1,397)
GLATIRAMER (1,291)
EPOPROSTENOL (1,256)
Which OBINUTUZUMAB Alternatives Have Lower Flushing Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE